EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model

Yvonne Sleiman iD, Jean-Baptiste Reisqs, Mohamed Boutjdir

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yvonne Sleiman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY 11209, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Sinoatrial Node, Induced Pluripotent Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NHLBI NIH HHS, US Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are widely used for disease modeling and pharmacological screening. However, their application has mainly focused on inherited cardiopathies affecting ventricular cardiomyocytes, leading to extensive knowledge on generating ventricular-like hiPSC-CMs. Electronic pacemakers, despite their utility, have significant disadvantages, including lack of hormonal responsiveness, infection risk, limited battery life, and inability to adapt to changes in heart size. Therefore, developing an in vitro multiscale model of the human sinoatrial node (SAN) pacemaker using hiPSC-CM and SAN-like cardiomyocyte differentiation protocols is essential. This would enhance the understanding of SAN-related pathologies and support targeted therapies. Generating SAN-like cardiomyocytes offers the potential for biological pacemakers and specialized conduction tissues, promising significant benefits for patients with conduction system defects. This review focuses on arrythmias related to pacemaker dysfunction, examining protocols’ advantages and drawbacks for generating SAN-like cardiomyocytes from hESCs/hiPSCs, and discussing therapeutic approaches involving their engraftment in animal models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacSinoatrial NodeInduced Pluripotent Stem CellsCell DifferentiationBiological ClocksHumansAnimalsArrhythmias, Cardiac

Stichwörter der Autor:innen

SAN-like cardiomyocytesarrythmias-related pacemaker dysfunctionbiological pacemakershESCs and hiPSCs-directed pacemaker differentiation protocols

Autor:innen und Institutionen

  • Cardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY 11209, USA.
  • Department of Medicine, Cell Biology and Pharmacology, State University of New York Downstate Health Sciences University, New York, NY 11203, USA.
  • Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.

ORCID-Profile: Yvonne Sleiman

Förderung

  • BLRD VA
  • NHLBI NIH HHS
  • US Department of Defense
  • Biomedical Laboratory Research & Development Service of Veterans Affairs Office of Research and Development
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Sleiman, Y., Reisqs, J. B., & Boutjdir, M. (2024). Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179155

Vancouver

Sleiman Y, Reisqs JB, Boutjdir M. Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179155

BibTeX
@article{Sleiman2024,
  author = {Sleiman, Yvonne and Reisqs, Jean-Baptiste and Boutjdir, Mohamed},
  title = {Differentiation of Sinoatrial-like Cardiomyocytes as a Biological Pacemaker Model},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179155}
}
Kostenlos starten →